FEB 08, 2019 9:11 PM PST

Bodybuilding Supplement Harms Brain Cells

WRITTEN BY: Nouran Amin

Researchers at University of Technology Sydney warn that the protein supplement, L-norvaline, could damage brain cells. The study was published in Toxicology in Vitro describes how at low concentrations, L-norvaline induces unhealthy cells in the brain. The was the first reporting to investigate the toxicity of L-norvaline in human cells with a specific focus on the health of brain cells.

L-norvaline is a widely used bodybuilding supplement and promoted as a compound that can boost workouts and aid recovery. Naturally, our bodies use amino acids from our diet to make new proteins—however, L-norvaline is one of the amino acids that are not usually used by our physiological system to produce proteins.

Learn more about bodybuilding supplements:

"Protein requirements are higher in very active individuals and proteins are considered to improve and increase performance. The demand for amino acids in supplements has expanded but in addition to the normal protein-building amino acids other 'non-protein' amino acids are being taken," explains lead author, Kate Samardzic, a PhD candidate at UTS School of Life Sciences. "Some non-protein amino acids are toxic because they can mimic protein amino acids and deceive the body into making faulty proteins; a property used by some plants to kill predators.

Although it has been known that L-norvaline helps to produce more energy, it is now believed to damage the machinery used to generate that energy—producing long-term consequences for anyone who takes the supplement.

“Some plants can even release non-protein amino acids into the soil to kill other plants so that they can have access to all the nutrients. Chemical warfare among plants is a wellknown phenomenon. Since there was evidence that L-norvaline has an antimicrobial and herbicidal activity we examined its toxicity in human cells,” said Samardzic

Source: Science Daily

About the Author
  • Nouran earned her BS and MS in Biology at IUPUI and currently shares her love of science by teaching. She enjoys writing on various topics as well including science & medicine, global health, and conservation biology. She hopes through her writing she can make science more engaging and communicable to the general public.
You May Also Like
OCT 07, 2020
Cancer
Delivering Cancer Drugs to Osteosarcoma with Nanoparticles
OCT 07, 2020
Delivering Cancer Drugs to Osteosarcoma with Nanoparticles
Over the years, cancer researchers have struggled not just with drug and diagnostic design, but with drug delivery. The ...
OCT 23, 2020
Drug Discovery & Development
FDA Gives Full Approval to Remdesivir to Treat COVID-19
OCT 23, 2020
FDA Gives Full Approval to Remdesivir to Treat COVID-19
The US Food and Drug Administration (FDA) has approved antiviral drug Remdesivir, sold under the name ‘Velkury&rsq ...
OCT 18, 2020
Drug Discovery & Development
Virus-Mimicking Drug
OCT 18, 2020
Virus-Mimicking Drug
Scientists have found drug that a drug activates the body’s immune system by behaving like a virus and may make ce ...
NOV 06, 2020
Immunology
The Coronavirus Is No Match Against Sybody 23
NOV 06, 2020
The Coronavirus Is No Match Against Sybody 23
The virus that causes COVID-19, SARS-CoV-2, uses its spike protein to gain access to cells, by binding to the ACE2 recep ...
NOV 15, 2020
Drug Discovery & Development
Antidepressant May Prevent Worsening of COVID-19 Infections
NOV 15, 2020
Antidepressant May Prevent Worsening of COVID-19 Infections
  Researchers from the Washington University School of Medicine in St. Louis have found that fluvoxamine, a common ...
NOV 28, 2020
Microbiology
Potential Treatment ID'ed for Emerging Viral Disease
NOV 28, 2020
Potential Treatment ID'ed for Emerging Viral Disease
A mosquito-borne virus called VEEV has been emerging in South America. It causes symptoms that make it difficult to dist ...
Loading Comments...